Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Chimerix
Chimerix
Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa
Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa
Fierce Pharma
Chimerix
monkeypox
Emergent BioSolutions
Tembexa
antivirals
Flag link:
US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout
US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout
Fierce Pharma
Chimerix
monkeypox
Tembexa
government contract
antivirals
Flag link:
Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table
Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table
Endpoints
monkeypox
antivirals
SIGA technologies
Chimerix
Flag link:
To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech
To focus on cancer, Chimerix sells rights to antiviral drug that defined the biotech
MedCity News
Chimerix
cancer
smallpox
Tembexa
Flag link:
Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19
Chimerix starts Phase II/III trial of heparin-derived blood cancer drug in Covid-19
MedCity News
Chimerix
DSTAT
cytokines
clinical trials
COVID-19
pandemic
strokes
Heparin
Flag link:
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Endpoints
Chimerix
patients
clinical trials
Brincidofovir
Flag link:
Chimerix cuts workforce by 20 percent after 'unexpected' trial results
Chimerix cuts workforce by 20 percent after 'unexpected' trial results
Bizjournals.com
Chimerix
layoffs
Brincidofovir
Flag link:
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Chimerix scraps two PhIII trials as it regroups in wake of a setback
Fierce Biotech
Chimerix
clinical trials
Brincidofovir
CMV
antivirals
Flag link:
Chimerix shares crater after late-stage trial fails
Chimerix shares crater after late-stage trial fails
Marketwatch
Chimerix
clinical trials
Brincidofovir
Flag link:
Trial enrollment drives Durham-based Chimerix stock to all-time high
Trial enrollment drives Durham-based Chimerix stock to all-time high
Bizjournals.com
clinical trials
Chimerix
adenovirus
Brincidofovir
Flag link:
Chimerix aims to greatly increase R&D this year
Chimerix aims to greatly increase R&D this year
Bizjournals.com
Chimerix
R&D
Flag link:
Durham's Chimerix hits 'major milestone' in drug trial enrollment
Durham's Chimerix hits 'major milestone' in drug trial enrollment
Bizjournals.com
Chimerix
drug trials
cytomegalovirus
Brincidofovir
Flag link:
Analyst: Chimerix Govt. Smallpox Pact Worth Up To $435 Million
Analyst: Chimerix Govt. Smallpox Pact Worth Up To $435 Million
Yahoo/Benzinga
Chimerix
smallpox
government contracts
Flag link:
Biotech pros' top 8 stock picks
Biotech pros' top 8 stock picks
Fortune
biotech
Bluebird Bio
Chimerix
Puma Biotechnology
Incyte
Isis Pharmaceuticals
Celgene
Alexion
Regeneron
Flag link:
Chimerix to stop participation in clinical studies of Ebola drug
Chimerix to stop participation in clinical studies of Ebola drug
Yahoo/Reuters
Chimerix
ebola virus
Brincidofovir
Flag link:
Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
Yahoo/Bloomberg
Bill Gates
ebola virus
Chimerix
clinical trials
Flag link:
The Rationale For Using Brincidofovir (BCV) In Ebola Patients
The Rationale For Using Brincidofovir (BCV) In Ebola Patients
Forbes
Brincidofovir
ebola virus
Chimerix
Flag link:
Ebola Drug Race Ramps Up in Earnest
Ebola Drug Race Ramps Up in Earnest
WSJ
Tekmira Pharmaceuticals
Mapp Biopharmaceutical
Chimerix
Ebola
vaccines
Flag link:
Companies That Could Develop An Enterovirus Treatment
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Flag link:
Ebola Drug Stocks React Wildly to Dallas Patient Death
Ebola Drug Stocks React Wildly to Dallas Patient Death
24/7 Wall St
ebola virus
Tekmira
Biocryst
Chimerix
Sarepta Therapeutics
Flag link:
Pages
1
2
next ›
last »